Adage Capital Partners’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
JT
OCA
RCM
MB
PCH
Adage Capital Partners's BIOA Position: Q2 2026 in Review
Adage Capital Partners reduced its BioAge Labs (BIOA) stake by 40% in Q2 2026, selling an estimated $3.61M and leaving 300,000 shares worth $7.35M. The position accounts for 0.01% of the portfolio, ranked #763.
Adage Capital Partners first reported a position in BIOA in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.9M in Q4 2025. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.
- Adage Capital Partners held 300,000 shares of BioAge Labs worth $7.35M as of Q2 2026.
- Adage Capital Partners sold 200,000 BioAge Labs shares in Q2 2026, an estimated $3.61M.
- BioAge Labs made up 0.01% of Adage Capital Partners's portfolio in Q2 2026, its #763 holding.
- Adage Capital Partners first reported a position in BioAge Labs in Q4 2025 and has held it in 3 quarters since.
- Adage Capital Partners's BioAge Labs position peaked at $13.9M in Q4 2025.
- 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.